Wed, Mar 4, 2015, 2:34 AM EST - U.S. Markets open in 6 hrs 56 mins


% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • i832u i832u Oct 5, 2012 4:02 PM Flag

    Week after week this board idiots are so "sure" of so called buyout

    but nothing has happened only huge disappointment is coming.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • You're overlooking several fundamental points. There are no other $B opportunities that Phama
      can go after, and PFE, MRK AZN have had major revenue losses due to patent cliffs. Aside from
      a combo pill (Statin and Vascepa) all of the above would be very motivated to aquire AMRN. This
      can't happen until a proper valuation can be determined, and that can't occur until a decision is
      made on the NCE. I just happen to be in Industry, and can suggest that interest level is high. I am
      not involved with any of the above mentioned companies.

      Sentiment: Strong Buy

    • Reason is BID vs.ASKED
      In April/MAY 2011-- Bid was 15 and ASK was 30---check Bloomberg article on June10,2011.
      Now it is Bid 20$ and Ask is 30$/share.
      Lazard Ltd. has to bridge the gap somehow or find a compromise.

      Example: BMY bid 22$ for Amylin---Amaylin was asking 34$

      BMY upped the bid to 26$--but Amaylin changed ASK to 33$.

      Finally Goldman Sachs found Astra Zeneca to jointly bid with Bristol Myers.
      The bid was raised to 31$/share. Amaylin accepted.
      I owned AMLN--and read the bidding process in SEC report.
      Goldman Sachs played a great role.

      Lazard must be trying to narrow the gap -so Amarin's CEO accepts and can sell it to the Board of Directors and shareholders.

      Sentiment: Buy

1.540.00(0.00%)Mar 3 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.